Oricula Therapeutics
Oricula Therapeutics was founded in 2013, with the mission of developing drugs that will prevent hearing loss as a result of using ototoxic drugs such as aminoglycosides which are important antibiotics, but whose side effects include hearing loss. They are currently in the process of filing for Investigational New Drug (IND) with the FDA.
Clinical trials to be announced.
RECENT NEWS ON ORICULA THERAPEUTICS
COMPANY OVERVIEW
Locations: United States
Year Founded: 2013
CEO: Malcolm Gleser (MD, Ph.D.)
Nothing Found
Sorry, no posts matched your criteria